{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-240253","form_type":"8-K","ticker":"HRTX","cik":"0000818033","company_name":"HERON THERAPEUTICS, INC. /DE/","filed_at":"2025-10-15T23:59:59+00:00","discovered_at":"2026-05-14T18:02:42.255916+00:00","generated_at":"2026-05-17T03:49:11.291751+00:00","sec_items":["5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Heron shareholders approve share issuances exceeding 19.99% threshold","bullets":["On Oct 13, 2025, shareholders approved issuance of shares upon conversion of convertible notes due 2031 (89.6M for, 5.6M against).","Shareholders also approved issuance upon automatic conversion of Series A Convertible Preferred Stock (91.5M for, 3.7M against).","Both proposals passed to comply with Nasdaq Listing Rule 5635(d) for potential issuances exceeding 19.99% of outstanding common stock."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-240253","json":"https://secwatch.observer/filing/0001193125-25-240253.json","markdown":"https://secwatch.observer/filing/0001193125-25-240253.md","text":"https://secwatch.observer/filing/0001193125-25-240253.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/818033/000119312525240253/0001193125-25-240253-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/818033/000119312525240253/hrtx-20251015.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T03:49:11.291751+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}